<section><div class="Schedule"><header><h2 class="scheduleLabel" id="h-3.141516"><span class="scheduleLabel">SCHEDULE V</span><span class="OriginatingRef">(Sections 2, 4, 6, 55 and 60)</span></h2></header><ul class="ProvisionList"><li><p class="indent-0-1"><span class="lawlabel">1</span> <span class="Repealed">[Repealed, SOR/2002-361, s. 1]</span></p></li><li><p class="indent-0-1"><span class="lawlabel">2</span> Propylhexedrine (1–cyclohexyl–2–methylaminopropane) and any salt thereof</p></li><li><p class="indent-0-1"><span class="lawlabel">3</span> Pyrovalerone (1–(1–pyrrolidinyl)butyl p–tolyl ketone and any salt thereof</p></li></ul><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem">1996, c. 19, Sch. V</li><li class="HistoricalNoteSubItem"> SOR/2002–361, s. 1</li></ul></div></div></section>